Clinical Trial Update: A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating the safety and efficacy of RO7204239 in combination with risdiplam (RO7034067) for spinal muscular atrophy, and t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• RO7204239
• Risdiplam (risdiplam)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Spinal Muscular Atrophy (SMA) | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING